The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3

På svenska

Author

  • Rongxi Yang
  • Bowang Chen
  • Katrin Pfuetze
  • Stephan Buch
  • Verena Steinke
  • Elke Holinski-Feder
  • Sarah Stoecker
  • Witigo von schoenfels
  • Thomas Becker
  • Hans K. Schackert
  • Brigitte Royer-Pokora
  • Matthias Kloor
  • Wolff H. Schmiegel
  • Reinhard Buettner
  • Christoph Engel
  • Jesus Lascorz Puertolas
  • Asta Försti
  • Nelli Kunkel
  • Peter Bugert
  • Stefan Schreiber
  • Michael Krawczak
  • Clemens Schafmayer
  • Peter Propping
  • Jochen Hampe
  • Kari Hemminki
  • Barbara Burwinkel
Show all

Summary, in English

Colorectal cancer (CRC) is one of the most common cancer worldwide. However, a large number of genetic risk factors involved in CRC have not been understood. Copy number variations (CNVs) might partly contribute to the missing heritability of CRC. An increased overall burden of CNV has been identified in several complex diseases, whereas the association between the overall CNV burden and CRC risk is largely unknown. We performed a genome-wide investigation of CNVs on genomic DNA from 384 familial CRC cases and 1285 healthy controls by the Affymetrix 6.0 array. An increase of overall CNV burden was observed in familial CRC patients compared with healthy controls, especially for CNVs larger than 50kb (case/control ratio 1.66, P 0.025). In addition, we discovered for the first time a novel structural variation at 12p12.3 and determined the breakpoints by strategic PCR and sequencing. This 12p12.3 structural variation was found in four of 2862 CRC cases but not in 6243 healthy controls (P 0.0098). RERGL gene (RERG/RAS-like), the only gene influenced by the 12p12.3 structural variation, sharing most of the conserved regions with its close family member RERG tumor suppressor gene (RAS-like, estrogen-regulated, growth inhibitor), might be a novel CRC-related gene. In conclusion, this is the first study to reveal the contribution of the overall burden of CNVs to familial CRC risk and identify a novel rare structural variation at 12p12.3 containing RERGL gene to be associated with CRC.

Publishing year

2014

Language

English

Pages

315-323

Publication/Series

Carcinogenesis

Volume

35

Issue

2

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Cancer and Oncology

Status

Published

Research group

  • Family Medicine and Clinical Epidemiology

ISBN/ISSN/Other

  • ISSN: 0143-3334